YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Reckitt ends talks to buy Pfizer unit

Posted online

Reckitt Benckiser Group Plc has ended talks to potentially buy a portion of Pfizer Inc.'s consumer health division.

According to Bloomberg, the division is valued at $15 billion to $20 billion.

Reckitt CEO Rakesh Kapoor reportedly was mostly interested in Pfizer's U.S. Advil business but not everything else in the unit.

Read more from Bloomberg.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences